The Patent Cooperation Treaty, or the PCT as it is typically referred to, came into existence in 1970. It is open to States party to the Paris Convention for the Protection of Industrial Property ...

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using ...

“When one seeks international patent rights it is typically wise to draft the application so it would be appropriate in both the United States and China [since these countries] have among the most ...

Emilio Berkenwald of Berken IP examines Argentina’s continued absence from the Patent Cooperation Treaty, the practical ...

An “international patent” is a fiction that currently fails to exist. In other words, there is no single world organization that will provide patent rights to all countries with a single application.

TORONTO, June 26, 2024 /PRNewswire/ - Full Circle Lithium Corp. ("FCL" or the "Company") (TSXV: FCLI) (OTCQB: FCLIF), a USA-based lithium products manufacturer, reports that it has achieved a ...

NEW YORK, May 5, 2023 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, ...

QUÉBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a ...

WESTMINSTER, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted ...

OTTAWA, ON, July 29, 2021 /CNW/ - Tetra Bio-Pharma Inc ("Tetra" or the Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that ...

In an order dated January 23 2013, the Intellectual Property Appellate Board (IPAB), in Parikumar v Controller of Patents, directed the patent office to accept a national phase application filed with ...